AHA: Blacks, Hispanics Make Up 53 Percent of COVID-19 Deaths
MONDAY, Nov. 23, 2020 -- Due to disproportionate representation, Black and Hispanic patients bear much of the burden of mortality and morbidity related to COVID-19, according to a study published online Nov. 17 in Circulation to coincide with the American Heart Association Scientific Sessions 2020, held virtually from Nov. 13 to 17.
Fatima Rodriguez, M.D., M.P.H., from Stanford University in California, and colleagues examined racial/ethnic differences in presentation and outcomes for patients hospitalized with COVID-19. Data from the American Heart Association COVID-19 Cardiovascular Disease Registry were presented for the first 7,868 patients treated at 88 U.S. hospitals between Jan. 17 and July 22, 2020.
The researchers found that 33.0, 25.5, 6.3, and 35.2 percent of patients hospitalized with COVID-19 were Hispanic, non-Hispanic Black, Asian, and non-Hispanic White, respectively. The highest prevalence of obesity, hypertension, and diabetes was seen in Black patients. In addition, the highest rates of mechanical ventilation (23.2 percent) and renal replacement therapy (6.6 percent) occurred among Black patients, and they had the lowest rates of remdesivir use (6.1 percent). Overall mortality was 18.4 percent; more than half (53 percent) of all deaths occurred in Black and Hispanic patients. Compared with non-Hispanic Whites, the adjusted odds ratios for mortality were 0.93 (95 percent confidence interval, 0.76 to 1.14), 0.90 (95 percent confidence interval, 0.73 to 1.11), and 1.31 (95 percent confidence interval, 0.96 to 1.80) for Black, Hispanic, and Asian patients, respectively. Results were similar for major adverse cardiovascular events.
"The COVID-19 pandemic has shown a spotlight on racial and ethnic disparities in health care that have been happening for years," Rodriguez said in a statement.
© 2021 HealthDay. All rights reserved.
Posted: November 2020
Further Support and Information on COVID-19
Read this next
FRIDAY, Jan. 22, 2021 -- There was a significant decrease in the number of patients undergoing screening tests for cancer and in the number of resulting diagnoses of cancerous and...
FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome...
FRIDAY, Jan. 22, 2021 -- There was a decrease in the total number of pediatric emergency department visits in 2020, but the proportion of trauma-related visits increased,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.